Superoxide Is Involved in the Central Nervous System Activation and Sympathoexcitation of Myocardial Infarction-Induced Heart Failure

Circulation Research

Volumn 94, Issue 3, 2004, Pages 402-409

  Lindley, Timothy E ^a   Doobay, Marc F ^a   Sharma, Ram V ^a   Davisson, Robin L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Adenovirus; Angiotensin II; Brain; Reactive oxygen species; Superoxide dismutase

Indexed keywords

ADENOVIRUS VECTOR; ANGIOTENSIN; HEXAMETHONIUM; NORADRENALIN; OXYGEN RADICAL; PROTEIN FOS; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; BRAIN; CELL ACTIVATION; CELL COUNT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HEART FAILURE; HEART INFARCTION; HEART RATE; HEART VENTRICLE HYPERTROPHY; HYDROTHORAX; HYPERACTIVITY; IMMUNOHISTOCHEMISTRY; LEFT CORONARY ARTERY; MEAN ARTERIAL PRESSURE; MOUSE; NERVE CELL; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUPRAOPTIC NUCLEUS; SYMPATHETIC TONE; THALAMUS MIDLINE NUCLEUS;

ADENOVIRIDAE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BRAIN; GENETIC VECTORS; HEART FAILURE, CONGESTIVE; HUMANS; INJECTIONS, INTRAVENTRICULAR; LOSARTAN; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; NEURONS; PROTO-ONCOGENE PROTEINS C-FOS; SUPEROXIDE DISMUTASE; SUPEROXIDES; SYMPATHETIC NERVOUS SYSTEM;

EID: 1242342716     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000112964.40701.93     Document Type: Article

References (33)

1. Miller LW, Missov ED. Epidemiology of heart failure. Cardiol Clin. 2001;19:547-555.
2. Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation. 1998;97:282-289.
3. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999;341:577-585.
4. Rector TS, Olivari MT, Levine TB, Francis GS, Cohn JN. Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. Am Heart J. 1987;114:148-152.
5. Phillips MI, Sumners C. Angiotensin II in central nervous system physiology. Regul Pept. 1998;78:1-11.
6. Ferguson AV, Bains JS. Actions of angiotensin in the subfornical organ and area postrema: implications for long term control of autonomic output. Clin Exp Pharmacol Physiol. 1997;24:96-101.
7. Ku YH, Jia YF, Chang YZ. Mechanisms underlying pressor response of subfornical organ to angiotensin II. Peptides. 1999;20:171-176.
8. Potts PD, Hirooka Y, Dampney RA. Activation of brain neurons by circulating angiotensin II: direct effects and baroreceptor-mediated secondary effects. Neuroscience. 1999;90:581-594.
9. Leenen FH, Yuan B, Huang BS. Brain "ouabain" and angiotensin II contribute to cardiac dysfunction after myocardial infarction. Am J Physiol. 1999;277:H1786-H1792.
10. Sato T, Yoshimura R, Kawada T, Shishido T, Miyano H, Sugimachi M, Sunagawa K. The brain is a possible target for an angiotensin-converting enzyme inhibitor in the treatment of chronic heart failure. J Card Fail. 1998;4:139-144.
11. Zhang W, Huang BS, Leenen FH. Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction. Am J Physiol. 1999;276:H1608-H1615.
12. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol. 2000;279:L1005-L1028.
13. 2 in angiotensin II-induced vascular hypertrophy. Hypertension. 1998;32:488-495.
14. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, Davisson RL. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res. 2002;91:1038-1045.
15. Vahid-Ansari F, Leenen FH. Pattern of neuronal activation in rats with CHF after myocardial infarction. Am J Physiol. 1998;275:H2140-H2146.
16. Zhang ZH, Francis J, Weiss RM, Felder RB. The renin-angiotensin-aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure. Am J Physiol. 2002;283:H423-H433.
17. Sinnayah P, Lindley TE, Staber PD, Cassell MD, Davidson BL, Davisson RL. Selective gene transfer to key cardiovascular regions of the brain: comparison of two viral vector systems. Hypertension. 2002;39:603-608.
18. Bisley JW, Rees SM, McKinley MJ, Harris DK, Oldfield BJ. Identification of osmoresponsive neurons in the forebrain of the rat: a Fos study at the ultrastructural level. Brain Res. 1996;720:25-34.
19. Li YF, Patel KP. Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms. Acta Physiol Scand. 2003;177:17-26.
20. Nestler EJ, Barrot M, Self DW. ΔFosB: a sustained molecular switch for addiction. Proc Natl Acad Sci U S A. 2001;98:11042-11046.
21. Patel KP, Zhang PL, Krukoff TL. Alterations in brain hexokinase activity associated with heart failure in rats. Am J Physiol. 1993;265:R923-R928.
22. Johnson AK, Thunhorst RL. The neuroendocrinology of thirst and salt appetite: visceral sensory signals and mechanisms of central integration. Front Neuroendocrinol. 1997;18:292-353.
23. Oury TD, Card JP, Klann E. Localization of extracellular superoxide dismutase in adult mouse brain. Brain Res. 1999;850:96-103.
24. De Nicola AF, Seltzer A, Tsutsumi K, Saavedra JM. Effects of deoxycorticosterone acetate (DOCA) and aldosterone on Sar1-angiotensin II binding and angiotensin-converting enzyme binding sites in brain. Cell Mol Neurobiol. 1993;13:529-539.
25. Francis J, Weiss RM, Johnson AK, Felder RB. Central mineralocorticoid receptor blockade decreases plasma TNF-α after coronary artery ligation in rats. Am J Physiol. 2003;284:R328-R335.
26. Dunn AJ. Cytokine activation of the HPA axis. Ann N Y Acad Sci. 2000;917:608-617.
27. Suematsu N, Tsutsui H, Wen J, Kang D, Ikeuchi M, Ide T, Hayashidani S, Shiomi T, Kubota T, Hamasaki N, Takeshita A. Oxidative stress mediates tumor necrosis factor-α-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation. 2003;107:1418-1423.
28. Li Y, Zhang W, Stern JE. Nitric oxide inhibits the firing activity of hypothalamic paraventricular neurons that innervate the medulla oblongata: role of GABA. Neuroscience. 2003;118:585-601.
29. Rauch M, Schmid HA, deVente J, Simon E. Electrophysiological and immunocytochemical evidence for a cGMP-mediated inhibition of subfornical organ neurons by nitric oxide. J Neurosci. 1997;17:363-371.
30. Zaborszky L, Leranth C, Makara GB, Palkovits M. Quantitative studies on the supraoptic nucleus in the rat. II: afferent fiber connections. Exp Brain Res. 1975;22:525-540.
31. Swanson LW, Sawchenko PE. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci. 1983;6:269-324.
32. Pyner S, Coote JH. Identification of branching paraventricular neurons of the hypothalamus that project to the rostroventrolateral medulla and spinal cord. Neuroscience. 2000;100:549-556.
33. Zanzinger J, Czachurski J. Chronic oxidative stress in the RVLM modulates sympathetic control of circulation in pigs. Pflugers Arch Eur J Physiol. 2000;439:489-494.